{"id":"W2526572293","doi":"10.1007/s40487-016-0030-2","title":"Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma","year":2016,"lang":"en","type":"article","venue":"Oncology and Therapy","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Dabrafenib; Trametinib; Vemurafenib; Ipilimumab; Medicine; Dacarbazine; Internal medicine; Oncology; Hazard ratio; Progression-free survival; Melanoma; Confidence interval; Metastatic melanoma; Cancer research; Chemotherapy; Cancer; Biology; Immunotherapy; MAPK/ERK pathway","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02391516,0.002010595,0.006352181,0.003589527,0.0003837241,0.002342216,0.001476379,0.001386027,0.002811166],"category_scores_gemma":[0.03678813,0.0008156523,0.03420115,0.003097128,0.0003844436,0.0009233108,0.0008098446,0.001752948,0.0001743602],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00331836,"about_ca_system_score_gemma":0.002561308,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01870713,"about_ca_topic_score_gemma":0.02298327,"domain_scores_codex":[0.9848681,0.01211533,0.0008382113,0.001081625,0.0008484382,0.0002483575],"domain_scores_gemma":[0.9800679,0.01585015,0.002145769,0.0008597841,0.0008191706,0.0002573181],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.006034574,0.00004596548,0.02025001,0.0208268,0.9220338,0.0001299867,0.00003505911,0.01495367,0.0002769711,0.0004760743,0.001105832,0.01383136],"study_design_scores_gemma":[0.001380855,0.0004033584,0.01346464,0.002541756,0.9714341,0.0001218402,0.00002293049,0.006506418,0.0002202953,0.001376272,0.002496749,0.00003094153],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.10216,0.8739666,0.0106358,0.002977603,0.0006805082,0.0004851794,0.005726351,0.0002037044,0.003164174],"genre_scores_gemma":[0.8865477,0.1024205,0.005847198,0.001020088,0.0002973534,0.0005526141,0.002576546,0.00006468435,0.0006733319],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.02391516,"threshold_uncertainty_score":0.1264769,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05188755218340509,"score_gpt":0.320069913384466,"score_spread":0.2681823612010609,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}